{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T05:12:56Z","timestamp":1697433176681},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2000,8,31]],"date-time":"2000-08-31T00:00:00Z","timestamp":967680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,8,31]],"date-time":"2000-08-31T00:00:00Z","timestamp":967680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2000,9,1]]},"DOI":"10.1038\/sj.bmt.1702540","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:46:56Z","timestamp":1031154416000},"page":"483-487","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Docetaxel effectively mobilizes peripheral blood CD34+ cells"],"prefix":"10.1038","volume":"26","author":[{"given":"HM","family":"Prince","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GC","family":"Toner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JF","family":"Seymour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Blakey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Gates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Eerhard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Chapple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Wall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Juneja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EH","family":"Januszewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Scarlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Brettell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Rischin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,8,31]]},"reference":[{"key":"BF1702540_CR1","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1200\/JCO.1984.2.11.1281","volume":"2","author":"W Hyrniuk","year":"1984","unstructured":"Hyrniuk W, Bush H . The importance of dose intensity in chemotherapy of metastatic breast cancer J Clin Oncol 1984 2: 1281\u20131288","journal-title":"J Clin Oncol"},{"key":"BF1702540_CR2","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1200\/JCO.1997.15.8.2765","volume":"15","author":"LL Siu","year":"1997","unstructured":"Siu LL, Tannock IF . Chemotherapy dose escalation: case unproven J Clin Oncol 1997 15: 2765\u20132768","journal-title":"J Clin Oncol"},{"key":"BF1702540_CR3","first-page":"317","volume":"19","author":"GW Sledge","year":"1996","unstructured":"Sledge GW, Antman KH . Progress in chemotherapy for metastatic breast cancer Semin Oncol 1996 19: 317\u2013332","journal-title":"Semin Oncol"},{"key":"BF1702540_CR4","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1200\/JCO.1997.15.5.1870","volume":"15","author":"KH Antman","year":"1997","unstructured":"Antman KH, Rowlings PA, Vaughan WP et al. High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America J Clin Oncol 1997 15: 1870\u20131879","journal-title":"J Clin Oncol"},{"key":"BF1702540_CR5","first-page":"121","volume":"15","author":"WP Peters","year":"1996","unstructured":"Peters WP, Jones RB, Vredenburgh J et al. A large, prospective, randomized trial of high-dose combination alkylating agents (CPB) with autologous cellular support (ABMS) as consolidation for patients with metastatic breast cancer achieving a complete remission after intensive doxorubicin-based induction therapy (AFM) Proc Am Soc Clin Oncol 1996 15: 121\u2013149","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF1702540_CR6","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1200\/JCO.1995.13.10.2483","volume":"13","author":"WR Bezwoda","year":"1995","unstructured":"Bezwoda WR, Seymour L, Dansey RD . High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial J Clin Oncol 1995 13: 2483\u20132489","journal-title":"J Clin Oncol"},{"key":"BF1702540_CR7","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1056\/NEJM200004133421501","volume":"342","author":"EA Stadtmauer","year":"2000","unstructured":"Stadtmauer EA, O'Neill LJ, Goldstein LJ et al. Conventional-dose chemotherapy compared to high-dose chemotherapy plus autologous hematopoietic stem cell transplantation for metastatic breat cancer New Engl J Med 2000 342: 1069\u20131076","journal-title":"New Engl J Med"},{"key":"BF1702540_CR8","first-page":"43a 161","volume":"18","author":"JP Lotz","year":"1999","unstructured":"Lotz JP, Cure H, Janvier M et al. High-dose chemotherapy with hematopoietic stem cells transplantation for metastatic breast cancer: results of the French protocol PEGASE 04 Proc Am Soc Clin Oncol 1999 18: 43a 161","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF1702540_CR9","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1023\/A:1008317205955","volume":"10","author":"HM Prince","year":"1999","unstructured":"Prince HM, Millward MJ, Rischin D et al. Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with blood cell support for metastatic breast cancer: results of phase I study Ann Oncol 1999 10: 479\u2013481","journal-title":"Ann Oncol"},{"key":"BF1702540_CR10","first-page":"303","volume-title":"Autologous Blood and Marrow Transplantation: Proceedings of the Ninth International Symposium, Arlington, Texas","author":"HM Prince","year":"1999","unstructured":"Prince HM, Millward MJ, Blakey D et al. Repetitive high-dose therapy with peripheral blood progenitor support for metastatic and locally advanced breast cancer Autologous Blood and Marrow Transplantation: Proceedings of the Ninth International Symposium, Arlington, Texas Charlottesville, Virginia: Carden Jennings Publishing 1999 303\u2013331"},{"key":"BF1702540_CR11","first-page":"702","volume":"26","author":"HM Prince","year":"1998","unstructured":"Prince HM, Bertoncello I, Millward M et al. Isolex 300i CD34-selected blood cells are capable of supporting multiple cycles of high-dose chemotherapy Exp Hematol 1998 26: 702\u2013768","journal-title":"Exp Hematol"},{"key":"BF1702540_CR12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1200\/JCO.1996.14.1.58","volume":"14","author":"C Hudis","year":"1996","unstructured":"Hudis C, Seidman A, Crown JPA et al. Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer J Clin Oncol 1996 14: 58\u201365","journal-title":"J Clin Oncol"},{"key":"BF1702540_CR13","first-page":"154a","volume":"16","author":"S Chan","year":"1997","unstructured":"Chan S, Friedrichs K, Noel D et al. A randomized phase III study of Taxotere versus doxorubicin in patients with metastatic breast cancer who have failed an alkylating containing regimen: preliminary results Proc Am Soc Clin Oncol 1997 16: 154a\u2013540","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF1702540_CR14","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1200\/JCO.1995.13.12.2886","volume":"13","author":"V Valero","year":"1995","unstructured":"Valero V, Holmes FA, Walters RS et al. Phase II trial of docetaxel: a new highly effective antineoplastic agent in the management of patients with anthracycline resistant metastatic breast cancer J Clin Oncol 1995 13: 2886\u20132894","journal-title":"J Clin Oncol"},{"key":"BF1702540_CR15","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1200\/JCO.1995.13.12.2879","volume":"13","author":"PM Ravdin","year":"1995","unstructured":"Ravdin PM, Burris HA, Cook G . Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancer J Clin Oncol 1995 13: 2879\u20132885","journal-title":"J Clin Oncol"},{"key":"BF1702540_CR16","first-page":"31A","volume":"31A","author":"JP Guastalla","year":"1995","unstructured":"Guastalla JP, Bonneterre J, Fumoleau P et al. A phase II trial of docetaxel in patients with anthracycline resistant metastatic breast cancer Eur J Cancer 1995 31A: (Suppl.5) 31A\u2013348","journal-title":"Eur J Cancer"},{"key":"BF1702540_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/sj.bmt.1701308","volume":"22","author":"P Chapple","year":"1998","unstructured":"Chapple P, Prince HM, Quinn M et al. Peripheral blood CD34-positive cell count reliably predicts autograft yield Bone Marrow Transplant 1998 22: 125\u2013130","journal-title":"Bone Marrow Transplant"},{"key":"BF1702540_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1089\/scd.1.1996.5.213","volume":"5","author":"DR Sutherland","year":"1996","unstructured":"Sutherland DR, Anderson L, Keeney M et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry J Hematother 1996 5: 213\u2013226","journal-title":"J Hematother"},{"key":"BF1702540_CR19","doi-asserted-by":"crossref","unstructured":"Prince HM, Rischin D, Tonor OC et al. Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study Bone Marrow Transplant 2000 (in press)","DOI":"10.1038\/sj.bmt.1702650"},{"key":"BF1702540_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/(SICI)1098-1101(1999)14:1<26::AID-JCA5>3.0.CO;2-1","volume":"14","author":"R Wilke","year":"1999","unstructured":"Wilke R, Brettell M, Prince HM et al. Comparison of COBE Spectra software version 4.7 and version 6.0 Auto PBSC Program J Clin Apheresis 1999 14: 26\u201330","journal-title":"J Clin Apheresis"},{"key":"BF1702540_CR21","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/sj.bmt.1701606","volume":"23","author":"HM Prince","year":"1999","unstructured":"Prince HM, Gardyn J, Millward MJ et al. Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancer Bone Marrow Transplant 1999 23: 427\u2013435","journal-title":"Bone Marrow Transplant"},{"key":"BF1702540_CR22","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/sj.bmt.1701599","volume":"23","author":"CH Weaver","year":"1999","unstructured":"Weaver CH, Schwartzberg LS, Zhen B et al. Mobilization of peripheral blood stem cells with docetaxel and cyclophosphamide (CY) in patients with metastatic breast cancer: a randomized trial of 3 vs 4g\/m2 of CY Bone Marrow Transplant 1999 23: 421\u2013425","journal-title":"Bone Marrow Transplant"},{"key":"BF1702540_CR23","first-page":"784 No.372","volume":"26","author":"C Corsini","year":"1998","unstructured":"Corsini C, Peccatori F, Mancuso P et al. Epirubicin and docetaxel is a very effective regimen for peripheral blood progenitor cells mobilization Exp Hematol 1998 26: 784 No.372","journal-title":"Exp Hematol"},{"key":"BF1702540_CR24","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1445-5994.1996.tb01931.x","volume":"26","author":"G Goss","year":"1996","unstructured":"Goss G, Szer J, Grigg A . Intermediate dose cyclophosphamide combined with a growth factor is a safe and effective regimen for mobilisation of peripheral blood progenitor cells Aust NZ J Med 1996 26: 411\u2013413","journal-title":"Aust NZ J Med"},{"key":"BF1702540_CR25","doi-asserted-by":"crossref","first-page":"404a 1602","DOI":"10.1182\/blood.V86.9.3381.bloodjournal8693381","volume":"86","author":"HM Prince","year":"1995","unstructured":"Prince HM, Imrie K, Keating A et al. Cyclophosphamide, adriamycin, 5 fluorouracil and G-CSF mobilization achieves high peripheral blood progenitor cell yield which can support multiple cycles of high-dose chemotherapy Blood 1995 86: (Suppl.1) 404a 1602","journal-title":"Blood"},{"key":"BF1702540_CR26","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/S0140-6736(88)92012-0","volume":"ii","author":"MA Socinski","year":"1988","unstructured":"Socinski MA, Cannistra SA, Elias A et al. Granulocyte\u2013macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man Lancet 1988 ii: 1194\u20131198","journal-title":"Lancet"},{"key":"BF1702540_CR27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1046\/j.1365-2141.1997.1812998.x","volume":"98","author":"IG McQuaker","year":"1997","unstructured":"McQuaker IG, Haynes AP, Stainer C et al. Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide Br J Haematol 1997 98: 228\u2013233","journal-title":"Br J Haematol"},{"key":"BF1702540_CR28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.bmt.1700870","volume":"20","author":"P Viens","year":"1997","unstructured":"Viens P, Gravis G, Genre D et al. High-dose sequential chemotherapy with stem cell support for non-metastatic breast cancer Bone Marrow Transplant 1997 20: 199\u2013203","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1702540.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702540","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702540.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T21:41:21Z","timestamp":1648071681000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1702540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8,31]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,9,1]]}},"alternative-id":["BF1702540"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1702540","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,8,31]]},"assertion":[{"value":"31 August 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}